Published studies of the serological markers of hepatitis A (anti-HAV) and hepatitis B (HBsAg, anti-HBs, and anti-HBc) in populations of the Asia-Pacific region have been tabulated and analysed for information about the extent and pattern of virus exposure, with a view to identifying areas in need of further study, and to formulating strategies for eventual immunisation programmes.
Hepatitis A infection is shifting to older age groups as it slowly disappears from developed countries such as Australia and Japan, and poses the paradox of fewer but potentially more severe illnesses. Except for some small island populations of Oceania, where it may strike periodically in epidemic fashion, hepatitis A continues to be an endemic, ubiquitous childhood infection in the rest of the Asia-Pacific region. As subclinical or mild infection is the rule in children, indiscriminate immunisation of the general population does not seem advisable.
Hepatitis B infection is also least common in Australia, and only moderately more frequent in New Zealand and Japan, which can probably afford to restrict immunisation to high-risk population subsets. Taiwan, southeast China, and most of the perimeter countries of the Western Pacific, show an early, high prevalence of infection, which when considered in the light of the high frequency of chronic hepatitis and hepatocellular carcinoma in these countries, justifies nation-wide immunisation programmes carried out in early childhood. Infection is also widespread among Oceanic populations, but as there is little or no information for most of these populations about the frequency of late sequelae of hepatitis B, immunisation may not be urgent, or even appropriate.
2. Gust ID: Comparison of the epidemiology of hepatitis A and B. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral Hepatitis. 1981 International Symposium. Philadelphia: Franklin Institute Press, 1982; 129–43.
4. Togashi T, Kuwajima S, Takebayashi Tet al: The prevalence of antibody to hepatitis A virus in different age groups of Hokkaido inhabitants. Hokkaido Igaku Zasshi1982; 57: 101–3.
5.
5. Fujiwara T, Chiba S, Nakao Tet al: Clinical and epidemiological studies on hepatitis B in children. Tohoku J Exp Med1977; 121: 281–7.
6.
6. Nakamura S: Serological markers of hepatitis A and B virus infection in university students. Tohoku J Exp Med1982; 138: 237–8.
7.
7. Nakamura S: Chronic hepatitis B and hepatitis B surface antigen carriers in university students. Tohoku J Exp Med1978; 124: 391–2.
8.
8. Ichida F, Suzuki S, Furuta Set al: Age specific prevalence of anti HA in Japan from multi-institutional analysis. Gastroenterol Jpn1981; 16: 384–8.
9.
9. Dienstag JL.Szmuness W, Stevens CEet al: Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis1978; 137: 328–40.
10.
10. Halliday JW.Oda T: Report of the survey of hepatitis antigens in the Asian-Pacific region. Ann Acad Med Singapore1980; 9: 133–5.
11.
11. Muro T, Munehisa T, Kono Ket al: Follow-up studies on serum antigens and antibodies in hepatitis B virus infection in Tomie-Town. Goto Island, Nagasaki Prefecture. Hepatology1983; 3: 1072.
12.
12. Scientific Group on Viral Hepatitis B and its Related Liver Disease. Manila, December 1982. (WHO Regional Of fice for the Western Pacific).
13.
13. Kashiwagi S, Hayashi J, Ikematsu Het al: Prevalence of antibody to hepatitis A virus in Okinawa and Kyushu, Japan. Am J Epidemiol1983; 117: 55–9.
14.
14. Nisnioka K, Levin AG, Simons MJ: Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease. Bull WHO1975; 52: 293–300.
15.
15. Nishioka K: Natural history of hepatitis B virus and human being. Trans Jpn Acad1982; 38: 1–19.
16.
16. Jiang Y: Epidemiological studies of viral hepatitis A and B in the People's Republic of China. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral Hepatitis. 1981 International Symposium. Philadelphia: Franklin Institute Press, 1982: 121–8.
17.
17. Hu M, Schenzle D, Deinhardt Fet al: Prevalence of markers of hepatitis A and B in the Shanghai area. J Infect Dis1983; 147: 360.
18.
18. Hwang LY.Beasley RP, Yang CSet al: Incidence of hepatitis A virus infection in children in Taipei, Taiwan. Intervirol1983; 20: 149–54.
19.
19. Sung JL, Chen OS, Yu JUet al: Hepatitis A virus infection in Taiwan: a hospital-based study. Trop Geog Med1980; 32: 324–8.
20.
20. Beasley RP, Hwang LY, Chia-Chin Let al: Incidence of hepatitis among students at a university in Taiwan. Am J Epidemiol1983; 117: 213–22.
21.
21. Szmuness W, Dienstag JL, Purcell RHet al: The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol1977; 106: 392–8.
22.
22. Beasley RP, Hwang LY, Lin CCet al: Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis1982; 146: 198–204.
23.
23. Wu JS, Chen CH, Chiang YHet al: Hepatitis B virus infection in Taiwan, with reference to anti-HBc versus HBsAg and anti-HBs. J Formosan Med Assoc1980; 79: 760–7.
24.
24. Chen OS, Sung JL: Hepatitis B virus infection on Taiwan. N Engl J Med1977; 297: 668–9.
25.
25. Beasley RP, Lin CC, Hwang LYet al: Hepatocellular carcinoma and HBV: a prospective study of 22, 707 men in Taiwan. Lancet1981; 2: 1129–33.
26.
26. Beasley RP, Lin CC, Chien CSet al: Geographic distribution of HBsAg carriers in China. Hepatology1982; 2: 553–6.
27.
27. Stevens CE, Beasley RP, Tsui Jet al: Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med1975; 292: 771–4.
28.
28. Lam KC, Yuen P, Colbourne MJet al: HBV markers in Chinese in Hong Kong. Ann Acad Med Singapore1980; 9: 149–51.
29.
29. Yeoh EK, Chang WK, Lo HYet al: Hepatitis B vaccination in health care personnel in a region of high prevalence. Hepatology1983; 3: 1079.
30.
30. Diwan A: Unpublished data. Personal communication, 1984.
31.
31. Khin MT: WHO meeting on prevention and control of liver cancer. In: Prevention of Liver Cancer. Geneva1983(WHO/CAN document).
32.
32. Snitbhan R, Scott RM, Bancroft WHet al: Subtypes of hepatitis B surface antigen in Southeast Asia. J Infect Dis1975; 131: 708–11.
33.
33. Skinhoj P, Aldershvile J, Black Fet al: Viral hepatitis in Southeas t Asian refugees. J Med Virol1981; 7: 149–55.
34.
34. Skinhoj P, Aldershvile J, Kjersem Met al: Hepatitis B infection in Vietnamese families. J Med Virol1983; 11: 125–9.
35.
35. Aldershvile J, Skinhoj P, Frosnor GGet al: The expression pattern of hepatitis B e antigen and antibody in different ethnic and clinical groups of hepatitis B surface antigen carriers. J Infect Dis1980; 142: 18–22.
36.
36. Stever W, Eschment R: Ergebnisse von Laboruntersuchungen bei eingereisten Vietnamesen (Kurzmitteilung). Off Gesundh-Wesen1980; 42: 89–90.
37.
37. Chaudhary RK, Nicholls ES, Kennedy DA: Prevalence of hepatitis B markers in Indochinese refugees. Can Med Assoc J1981; 125: 1243–6.
38.
38. Chadwick RG, Hall AJ, Davidson Iet al: Hepatitis B among Indochinese refugees in Great Britain. Postgrad Med J1982; 58: 676–9.
39.
39. Banffer JRJ: Markers of hepatitis B in a group of Vietnamese boat-refugees in the Netherlands. Trop Geog Afed1982; 34: 251–5.
40.
40. Welsh JD, Brown JD, Arnold Ket al: Hepatitis Bs antigen, malaria titers, and primary liver cancer in South Vietnam. Gastroenterol1976; 70: 392–6.
41.
41. Viranuvatti V, Hemindra P, Chainuvati T: Anti-HAV in Thai population. J Med Assoc Thai1982; 65: 379–82.
42.
42. Burke DS, Snitbhan R, Johnson DE: Age-specific prevalence of hepatitis A virus antibody in Thailand. Am J Epidemiol1981; 113: 245–9.
43.
43. Grossman RA, Benenson MW, Scott RMet al: An epidemiologic study of hepatitis B virus in Bangkok, Thailand. Am J Epidemiol1975; 101: 144–59.
44.
44. Punyagupta SLC, Olson LC, Harinasuta Uet al: The epidemiology of hepatitis B antigen in a high prevalence area. Am J Epidemiol1973; 97: 349–54.
45.
45. Pongpipat D, Suvatte V, Assateerawatts A: Prevalence of HBsAg, e-antigen and anti-e among Thai medical students. J Med Assoc Thai1979; 62: 26–33.
46.
46. Johnson DE, Snitbhan R, Scott RMet al: Hepatitis B in the rural tropics. Int J Epidemiol1980; 9: 123–9.
47.
47. Suskind RM, Olson LC, Olson RE: Protein calorie malnutrition and infection with hepatitis-associated antigen. Pediatrics1973; 51: 525–30.
48.
48. Ton SH, Lopez CG, Hasnah H: Prevalence of anti-HBc in Malaysian male blood donors and its correlation with DNA polymerase activity. Southeast Asian J Trop Med Pub Hlth1979; 10: 1–6.
49.
49. Ton SH, Lopez CG, Noriah R: HBeAg and anti-HBe in the Malaysian population and in Malaysian prisoners. Southeast Asian J Trop Med Pub Hlth1983; 14: 252–4.
50.
50. Ton SH, Lopez CG, Noriah R: Assessment of infectiousness of male Malaysian blood donors. Vox Sang1983; 45: 389–91.
51.
51. Kamath S: Hepatitis B surface antigen subtypes in Malaysia. Am J Epidemiol1975; 102: 191–5.
52.
52. Quak SH, Singh R, Oon CJet al: The immune status of Singapore children to hepatitis B virus. Aust Paediatr J1983; 19: 100–3.
53.
53. Quak SH, Singh R, Oon CJet al: A cross-sectional study of hepatitis B immune status in Asian children in Singapore. Ann Trop Paediatr1982; 2: 53–6.
54.
54. Chan SH: Chronic hepatitis in Singapore. Ann Acad Med Singapore1980; 9: 179–81.
55.
55. Brown P, Breguet G, Smallwood Let al: Serologic markers of hepatitis A and B in the population of Bali, Indonesia. Am J Epidemiol1984.
56.
56. Breguet G, Ney R, Grimm Wet al: Genetic survey of an isolated community in Bali, Indonesia. I. Blood Groups, serum proteins and hepatitis B serology. Hum Hered1982; 32: 52–61.
57.
57. Mboi N, Olson JG, McGreevy PBet al: Estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia. Int J Epidemiol1981; 10: 367–72.
58.
58. Akbar N, Sulaiman A, Sjaifoellah Noer HMet al: Hepatitis B virus infection in a normal young population in Jakarta, Indonesia. Hepatology1983; 3: 1059.
59.
59. Lehman NI, Gust ID: The prevalence of antibody to hepatitis A virus in two populations in Victoria. Med J Aust1977; 2: 731–2.
60.
60. Gust ID, Lehmann NI, Lucas CR: Relationship between prevalence of antibody to hepatitis A antigen and age: a cohort effect?J Infect Dis1978; 138: 425–6.
61.
61. Whelan G, Breen KJ, Fry C: Prevalence of hepatitis B in a general hospital staff. Med J Aust1979; 1: 374–6, 401.
62.
62. Gust ID, Dimitrakakis M. Prevalence of antibody to hepatitis B virus in Melbourne. Med J Aust1978; 1: 39–40.
63.
63. Boughton CR, Hawkes RA, Ferguson V: Viral hepatitis A and B: a sero-epidemiological study of a non-hepatic Sydney population. Med J Aust1980; 1: 177–180.
64.
64. Barrett EJ: Hepatitis B in Australian aborigines and Torres Strait Islanders: geographical, age and familial distribution of antigen subtypes and antibody. Aust NZ J Med1976; 6: 106–11.
65.
65. Cossart YE, Kirsch S, Ismay SL: Post-transfusion hepatitis in Australia: report of the Australian Red Cross study. Lancet1982; 1: 208–13.
66.
66. Beal RW: Hepatitis B antigen screening in South Australia and Northern Territory blood donors. Pathol1976; 8: 21–7.
67.
67. Burrell CJ, Cameron AS, Hart Get al: Hepatitis B reservoirs and attack rates in an Australian community. Med J Aust1983; 2: 492–6.
68.
68. Wands JR, Marciniak RA, Isselbacher KJ: Demonstration of previously undetected hepatitis B viral determinants in an Australian aboriginal population by monoclonal anti-HBs antibody radioimmunossays. Lancet1982; 1: 977–80.
69.
69. Blumberg BS, Mazzur S, Hertzog Ket al: Australia antigen in the Solomon Islands. Hum Biol1974; 46: 239–62.
70.
70. Austin FJ, Maguire T, Jennings LCet al: The prevalence of antibodies to hepatitis A and B viruses in Port Chalmers residents. NZ Med J1982; 95: 72–3.
71.
71. Faoagali JL, Young SA: Distribution of anti HBs in Christchurch hospital staff. NZ Med J1978; 87: 121–3.
72.
72. Faoagali JL, Booth PB: Hepatitis B surface antigen and antibody among Samoans living in Christchurch. NZ Med J1977; 85: 278–80.
73.
73. Nicholson G: Incidence of hepatitis B-antigenaemia and positive alphafoetoprotein in New Zealand, Western Samoa, and Tonga — (a pilot study of Polynesian liver disease). Ann Acad Med Singapore1980; 9: 201–2.
74.
74. Milne A, Moyes CD: Hepatitis B carriage in children. NZ Med J1983; 96: 238–41.
75.
75. Milne A: Viral hepatitis in the eastern Bay of Plenty. NZ Med J1980; 92: 87–91.
76.
76. Hawkes RA, Boughton CR, Ferguson V: The seroepidemiology of hepatitis in Papua New Guinea. I. A long-term study of hepatitis A. Am J Epidemiol1981; 114: 554–62.
77.
77. Hawkes RA, Boughton CR, Ferguson Vet al: The seroepidemiology of hepatitis in Papua New Guinea. I. A long-term study of hepatitis B. Am J Epidemiol1981; 114: 563–73.
78.
78. Simons MJ, Binns CW, Malcolm LAet al: Australia antigen frequencies in two groups of highland New Guineans. Papua New Guinea Med J1972; 15: 91–7.
79.
79. Woodfield DG: Acute viral hepatitis in Papua New Guinea: results of hepatitis B antigen and antibody studies. Trop Geog Med1975; 27: 399–404.
80.
80. Woodfield DGOraka RE, Nelson M: Australia antigen in Papua New Guinea. Med J Aust1972; 2: 469–72.
81.
81. Drew J, London WT, Blumberg BSet al: Hepatitis B virus and sex ratio on Kar Kar Island. Hum Biol1982; 54: 123–35.
82.
82. Gaxotte P, Coulaud JP, Saimot Jet al: Hepatitis B antigenaemia on Wuvulu Island. Am J Trop Med Hyg1978; 27: 1037–40.
83.
83. Wong DC, Purcell RH, Rosen L: Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific. Am J Epidemiol1979; 110: 227–36.
84.
84. Mazzur S, Jones N: Limited family clustering of hepatitis B surface antigen in a Melanesian population. Am J Epidemiol1977; 105: 113–7.
85.
85. Mazzur S, Bastiaans JS, Nath N: Hepatitis B virus (HBV) infection among children and adults in the Solomon Islands. Am J Epidemiol1981; 113: 510–19.
86.
86. Mazzur S: Subtypes of HBsAg in Oceania. Bibl Haematol1976; 42: 48–52.
87.
87. Austin FJ, Maguire T, Miles JAR: The occurrence of hepatitis B antigen and antibody in some population groups in the southwest Pacific region. Am J Epidemiol1974; 23: 489–94.
88.
88. Kuberski T, LeGonidec G, Gust IDet al: Hepatitis B virus infections in Melanesians and Polynesians in New Caledonia. Am J Epidemiol1981; 114: 355–61.
89.
89. Gust ID, Lehmann NI, Dimitrakakis M: A seroepidemiologic study of infection with HAV and HBV in five Pacific islands. Am J Epidemiol1979; 110: 237–42.
90.
90. Zhuang H, Coulepis AG, Zimmet Pet al: Seroepidemiology of infection with hepatitis B virus in Fiji. Am J Epidemiol1982; 116: 608–16.
91.
91. Gerety RJ, Hoofnagle JH, Markenson JAet al: Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children. J Pediatr1974; 84: 661–5.
92.
92. Blumberg BS, Alter JH, Visnich S: A “new” antigen in leukemic sera. J Am Med Assoc1965; 191: 541–6.
93.
93. Gust ID, Dimitrakakis M, Zimmet P: Studies on hepatitis B surface antigen and antibody in Nauru. I. Distribution among Nauruans. Am J Trop Med Hyg1978; 27: 1030–6.
94.
94. Gust ID, Dimitrakakis, Bott Fet al: Studies on hepatitis B surface antigen and antibody in Nauru. II. Distribution amongst Gilbert and Ellice (Tuvalu) islanders. Am J Trop Med Hyg1978; 27: 1206–9.
95.
95. Gust ID, Lehmann NI, Dimitrakakis Met al: Seroepidemiology of infection with hepatitis A and B viruses in an isolated Pacific population. J Infect Dis1979; 139: 559–63.
96.
96. Zhuang H, Coulepis AG, Gust IDet al: A cross sectional study of markers of hepatitis B infection in Niue. NZ Med J1983; 96: 330–2.
97.
97. Gust ID, Dimitrakakis M, Faaiuso Set al: The prevalence of hepatitis B infection amongst urban and rural populations in Western Samoa. J Hyg Camb1981; 86: 87–93.
98.
98. Lewis BD: Hepatitis B Virus Infection Among Native Inhabitants of French Polynesia: A Seroepidemiologic and Genetic Analysis. This is submitted to the Yale University School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Medicine. March 1981.
99.
99. Ohbayashi A, Okachi K, Mayumi M: Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterol1972; 62: 618–25.
100.
100. Okada K, Yamada T, Miyakawa Yet al: Hepatitis B surface antigen in the serum of infants after delivery from asymptomatic carrier mothers. J Pediatr1975; 87: 360–3.
101.
101. Nishioka K: Predominant Mode of Transmission of Hepatitis B Virus: Perinatal Transmission in Asian Regions. Manuscript, 1984.
